ID: ALA508949

Max Phase: Preclinical

Molecular Formula: C3H6ClN3OS

Molecular Weight: 131.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCc1nnc(S)o1

Standard InChI:  InChI=1S/C3H5N3OS.ClH/c4-1-2-5-6-3(8)7-2;/h1,4H2,(H,6,8);1H

Standard InChI Key:  UZJMOGLTRDKRCS-UHFFFAOYSA-N

Associated Targets(non-human)

GABA receptor alpha-6 subunit 76 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 131.16Molecular Weight (Monoisotopic): 131.0153AlogP: -0.18#Rotatable Bonds: 1
Polar Surface Area: 64.94Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.07CX Basic pKa: 7.19CX LogP: -1.51CX LogD: -1.67
Aromatic Rings: 1Heavy Atoms: 8QED Weighted: 0.52Np Likeness Score: -1.55

References

1. Jansen M, Rabe H, Strehle A, Dieler S, Debus F, Dannhardt G, Akabas MH, Lüddens H..  (2008)  Synthesis of GABAA receptor agonists and evaluation of their alpha-subunit selectivity and orientation in the GABA binding site.,  51  (15): [PMID:18651727] [10.1021/jm701562x]

Source